190 related articles for article (PubMed ID: 37352875)
1. Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.
Nicholson BD; Oke J; Virdee PS; Harris DA; O'Doherty C; Park JE; Hamady Z; Sehgal V; Millar A; Medley L; Tonner S; Vargova M; Engonidou L; Riahi K; Luan Y; Hiom S; Kumar H; Nandani H; Kurtzman KN; Yu LM; Freestone C; Pearson S; Hobbs FR; Perera R; Middleton MR
Lancet Oncol; 2023 Jul; 24(7):733-743. PubMed ID: 37352875
[TBL] [Abstract][Full Text] [Related]
2. Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study.
Schrag D; Beer TM; McDonnell CH; Nadauld L; Dilaveri CA; Reid R; Marinac CR; Chung KC; Lopatin M; Fung ET; Klein EA
Lancet; 2023 Oct; 402(10409):1251-1260. PubMed ID: 37805216
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
Klein EA; Richards D; Cohn A; Tummala M; Lapham R; Cosgrove D; Chung G; Clement J; Gao J; Hunkapiller N; Jamshidi A; Kurtzman KN; Seiden MV; Swanton C; Liu MC
Ann Oncol; 2021 Sep; 32(9):1167-1177. PubMed ID: 34176681
[TBL] [Abstract][Full Text] [Related]
5. Modeled residual current cancer risk after clinical investigation of a positive multicancer early detection test result.
Hudnut AG; Hubbell E; Venn O; Church TR
Cancer; 2023 Jul; 129(13):2056-2063. PubMed ID: 36943898
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.
Chen X; Dong Z; Hubbell E; Kurtzman KN; Oxnard GR; Venn O; Melton C; Clarke CA; Shaknovich R; Ma T; Meixiong G; Seiden MV; Klein EA; Fung ET; Liu MC
Clin Cancer Res; 2021 Aug; 27(15):4221-4229. PubMed ID: 34088722
[TBL] [Abstract][Full Text] [Related]
7. The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.
Tafazzoli A; Ramsey SD; Shaul A; Chavan A; Ye W; Kansal AR; Ofman J; Fendrick AM
Pharmacoeconomics; 2022 Nov; 40(11):1107-1117. PubMed ID: 36038710
[TBL] [Abstract][Full Text] [Related]
8. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
9. Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests.
Gelhorn H; Ross MM; Kansal AR; Fung ET; Seiden MV; Krucien N; Chung KC
Patient; 2023 Jan; 16(1):43-56. PubMed ID: 35844011
[TBL] [Abstract][Full Text] [Related]
10. A panel of seven protein tumour markers for effective and affordable multi-cancer early detection by artificial intelligence: a large-scale and multicentre case-control study.
Luan Y; Zhong G; Li S; Wu W; Liu X; Zhu D; Feng Y; Zhang Y; Duan C; Mao M
EClinicalMedicine; 2023 Jul; 61():102041. PubMed ID: 37387788
[TBL] [Abstract][Full Text] [Related]
11. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
12. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK.
Hackshaw A; Cohen SS; Reichert H; Kansal AR; Chung KC; Ofman JJ
Br J Cancer; 2021 Nov; 125(10):1432-1442. PubMed ID: 34426664
[TBL] [Abstract][Full Text] [Related]
13. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
14. Performance of a targeted methylation-based multi-cancer early detection test by race and ethnicity.
Tang WHW; Yimer H; Tummala M; Shao S; Chung G; Clement J; Chu BC; Hubbell E; Kurtzman KN; Swanton C; Roberts LR
Prev Med; 2023 Feb; 167():107384. PubMed ID: 36495927
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.
Banister K; Cook JA; Scotland G; Azuara-Blanco A; Goulão B; Heimann H; Hernández R; Hogg R; Kennedy C; Sivaprasad S; Ramsay C; Chakravarthy U
Health Technol Assess; 2022 Jan; 26(8):1-142. PubMed ID: 35119357
[TBL] [Abstract][Full Text] [Related]
16. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
17. The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice.
Nadauld LD; McDonnell CH; Beer TM; Liu MC; Klein EA; Hudnut A; Whittington RA; Taylor B; Oxnard GR; Lipson J; Lopatin M; Shaknovich R; Chung KC; Fung ET; Schrag D; Marinac CR
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298717
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
19. Modelled mortality benefits of multi-cancer early detection screening in England.
Sasieni P; Smittenaar R; Hubbell E; Broggio J; Neal RD; Swanton C
Br J Cancer; 2023 Jul; 129(1):72-80. PubMed ID: 37185463
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy study.
Taylor SA; Mallett S; Bhatnagar G; Morris S; Quinn L; Tomini F; Miles A; Baldwin-Cleland R; Bloom S; Gupta A; Hamlin PJ; Hart AL; Higginson A; Jacobs I; McCartney S; Murray CD; Plumb AA; Pollok RC; Rodriguez-Justo M; Shabir Z; Slater A; Tolan D; Travis S; Windsor A; Wylie P; Zealley I; Halligan S
Health Technol Assess; 2019 Aug; 23(42):1-162. PubMed ID: 31432777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]